Adnan Cetin
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 01, 2026
Multitarget Enzyme Inhibition and Anticancer Potential of 3-Substituted Indole Derivatives Supported by Molecular Docking Studies.Adnan Cetin, Ercan Oguz, Fikret Türkan
|Nov 06, 2025
Design, Synthesis, and Characterization of Novel Substituted 1,2,4-Triazines: Cytotoxic Activity on HepG2 and HT-29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies.Adnan Cetin, Ercan Oguz, Ewa Wolińska
|Jul 24, 2025
The Cytotoxic Effect on HepG2 Cell Line and In Vitro, In Silico Evaluation of 1,2,4-Triazine Compounds as Inhibitors of Acetylcholinesterase and Glutathione S-Transferase.Fikret Türkan, Adnan Cetin, Semanur Kalkan
|Jan 21, 2025
Promising Anticancer Activity of Pyrazole Compounds against Glioblastoma Multiforme: Their Synthesis, In vitro, and Molecular Docking Studies.Kemal Alp Nalcı, Cihat Mete, Zeynep Demir
|May 21, 2024
Synthesis and examination of 1,2,4-triazine-sulfonamide hybrids as potential inhibitory drugs: Inhibition effects on AChE and GST enzymes in silico and in vitro conditions.Przemysław Rozbicki, Ercan Oğuz, Ewa Wolińska
|Nov 10, 2023
Recent Advances in Pyrazole-based Protein Kinase Inhibitors as Emerging Therapeutic Targets.Adnan Cetin
Pageof 1
